Karen M Yates

Title: The Innovative Contributions of Karen M. Yates

Introduction

Karen M. Yates is a prominent inventor based in Fishers, IN (US). She has made significant contributions to the field of pharmaceuticals, particularly in the development of compounds that exhibit anti-cancer and anti-proliferative activities. With a total of 2 patents to her name, her work is paving the way for advancements in cancer treatment and other related diseases.

Latest Patents

Karen's latest patents include "N-acyl-N'-(pyridin-2-yl) ureas and analogs exhibiting anti-cancer and anti-proliferative activities." This patent describes compounds that are useful in treating cancer, autoimmune diseases, and metabolic bone disorders through the inhibition of c-FMS (CSF-1R), c-KIT, and/or PDGFR kinases. Additionally, she holds a patent for "Imidazolidinones and analogs exhibiting anti-cancer and anti-proliferative activities," which also focuses on similar therapeutic applications.

Career Highlights

Karen M. Yates is currently associated with Deciphera Pharmaceuticals, LLC, where she continues to innovate and contribute to the pharmaceutical industry. Her work is instrumental in developing new treatments that target critical pathways in various diseases.

Collaborations

Some of her notable coworkers include Daniel L. Flynn and Timothy Malcolm Caldwell, who collaborate with her in advancing research and development efforts at Deciphera Pharmaceuticals.

Conclusion

Karen M. Yates exemplifies the spirit of innovation in the pharmaceutical field. Her patents and ongoing work contribute significantly to the fight against cancer and other serious diseases.